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Abstract
Low-energy laser irradiation (LELI) drives quiescent skeletal muscle satellite cells into the cell cycle and enhances their proliferation,
thereby promoting skeletal muscle regeneration. Ongoing protein synthesis is a prerequisite for these processes. Here, we studied the
signaling pathways involved in the LELI regulation of protein synthesis. High levels of labeled [35S]methionine incorporation were detected
in LELI cells as early as 20 min after irradiation, suggesting translation of pre-existing mRNAs. Induced levels of protein synthesis were
detected up until 8 h after LELI implying a role for LELI in de novo protein synthesis. Elevated levels of cyclin D1, associated with
augmented phosphorylation of the eukaryotic initiation factor 4E (eIF4E) and its inhibitory binding protein PHAS-I, suggested the
involvement of LELI in the initiation steps of protein translation. In the presence of the MEK inhibitor, PD98059, eIF4E phosphorylation was
abolished and levels of cyclin D1 were dramatically reduced. The LELI-induced PHAS-I phosphorylation was abolished after preincubation
with the PI3K inhibitor, Wortmannin. Concomitantly, LELI enhanced Akt phosphorylation, which was attenuated in the presence of
Wortmannin. Taken together, these results suggest that LELI induces protein translation via the PI3K/Akt and Ras/Raf/ERK pathways.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Skeletal muscle regeneration is dependent on the prolif-
eration and differentiation of satellite cells [1–4]. These
cells are normally quiescent; however, in response to stimuli
such as myotrauma, they become activated, proliferate and
fuse into existing muscle fibers, or form new myofibers
[5,6]. Recent studies have shown that low-energy laser
irradiation (LELI) significantly enhanced the regeneration
process; LELI of injured limb muscle in rat and toad
induced young myofiber formation by two- and eightfold,
respectively [7,8]. LELI has been shown to modulate other
various biological processes such as increasing mitochon-
drial respiration and ATP synthesis and accelerating wound
healing [9,10]. Recently, it was shown in ischemic heart that
mitochondria were preserved and ATP-content was higher
in irradiated hearts as compared to nonirradiated ones [11].
The most commonly used irradiation apparatus is the
helium–neon (He–Ne) laser, which projects a beam at an
optimal wavelength of 632.8 nm [12,13].
Extracts from crushed adult skeletal muscles or hepato-
cyte growth factor (HGF) supplementation, in vitro and in
vivo, have been shown to induce cell-cycle entry of dormant
satellite cells [14–16]. Likewise, we recently showed that
LELI promotes activation of quiescent satellite cells, and
enhances their proliferation and survival in both mass
cultures and isolated muscle fibers [17,18]. LELI promotes
cell proliferation by inducing tyrosine-kinase receptor phos-
phorylation, which in turn activates the extracellular signal-
regulated protein kinase ERK1/2 [19], followed by the
induction of early-G1 phase regulatory proteins [17]. Pre-
vious studies have shown that induction of early-G1 phase
regulatory proteins, such as c-myc [20] and cyclin D1 [21],
requires de novo mRNA and protein synthesis, resulting
from translation of pre-existing mRNAs [22–25]. Many of
these mRNAs typically have a highly structured 5V-UTR,
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upstream AUGs and a poor sequence context for the
initiating AUG [26–29]. Eukaryotic initiation factor 4E
(eIF4E) is a major regulator of cap-dependent mRNA
translation in response to proliferative stimuli such as
hormones, growth factors and mitogens [30–34]. Three
mechanisms are known to regulate eIF4E: (i) modulation
of eIF4E expression levels [27,35]; (ii) phosphorylation of
eIF4E at Ser209, which increases its affinity to capped
mRNA [36]; and (iii) phosphorylation-dependent dissocia-
tion of a translational-repressor protein from eIF4E (i.e.
protein heat and acid stable; PHAS-I, also referred to as
eIF4E binding protein-1 4EBP1; [37,38]). The non- or
partially phosphorylated form of PHAS-I, which strongly
interacts with eIF4E, limits the latter’s availability of eIF4E
to the translation process. The mammalian target of rapa-
mycin (mTOR), a downstream kinase in the phosphoinosi-
tide 3-kinase (PI3K) pathway, is thought to phosphorylate
PHAS-I [39]. The fully phosphorylated PHAS-I dissociates
from eIF4E, allowing the latter to form the initiation
complex and translation to proceed [29,38,40].
Previously, it was shown that irradiation with He–Ne
laser increased cytosolic and mitochondrial protein syn-
thesis in isolated rat hepatocytes [41]. The present study
was aimed at investigating the effect of LELI on de novo
protein synthesis in the muscle cell system and to define the
involved signaling pathways. We focused on the regulation
of translation initiation, which is the rate-limiting step in
protein synthesis [30].
2. Materials and methods
2.1. Cell culture
i28 mouse myogenic cells [17,42] were grown in Dul-
becco’s modified Eagle medium (DMEM) supplemented
with 20% fetal calf serum (FCS). For the experiments, cells
were plated at 7 104 cells/60-mm petri dish, and main-
tained in serum-free DMEM for 36 h.
2.2. Laser irradiation
After 36 h of FCS deprivation, cells were irradiated
through a grid composed of 1.8 1.8 mm squares, for 3 s
per square, with a He–Ne laser (632.8 nm, 4.5 mW; 1.8-mm
beam diameter; Ealing Electro-Optics, Holliston, MA). This
methodology equalizes the effect on cells in the entire
tissue-culture plate [17,19]. After irradiation, cells were
maintained in serum-free DMEM for the indicated time
periods. Control, nonirradiated cells were maintained under
the same conditions as the LELI cells.
2.3. Metabolic labeling
Cells were deprived of methionine for 30 min in methio-
nine-free DMEM. [35S]methionine (1 ACi/ml, specific activ-
ity 1175 Ci/mmol; New England Nuclear, Boston, MA) was
added for 2 h to enable labeling of de novo protein syn-
thesis. Labeled cells were lysed in ice-cold NP-40-contain-
ing lysis buffer, sonicated and clarified by centrifugation at
10,000 g. Aliquots of 10 Al of whole-cell extracts were
dripped onto glass microfiber filters (Schleicher and
Schuell, Dassel, Germany), and proteins were precipitated
in ice-cold 10% (v/v) trichloroacetic acid (TCA) followed
by 5% TCA. Filters were dried for 30 min and then
immersed in Ultima Gold scintillation fluid (Packard,
Downers Grove, IL). Radioactivity was counted in a Tri-
Carb 1600CA scintillation counter (Packard).
2.4. Immunoprecipitation of eIF4E
Cells were lysed in NP-40-containing immunoprecipita-
tion lysis buffer as previously described [19]. Protein
extracts were sonicated and normalized for protein content
(BCA kit, Pierce, Rockford, IL). The lysates (50-Ag protein)
were incubated overnight at 4 jC with anti-eIF4E mono-
clonal antibody (Transduction Laboratories, Lexington, KY)
diluted 1:3000. This was followed by incubation with
protein A–Sepharose beads (Amersham Pharmacia Biotech,
Uppsala, Sweden) mixed at a ratio of 1:2 with protein L
beads (CBD, Rehovot, Israel) for 2 h at RT. The resulting
immunocomplex was washed three times in PBS and sub-
jected to electrophoresis (SDS-PAGE).
2.5. Western blot analysis
Cells were lysed in NP-40-based lysis buffer as previ-
ously described [17]. Extracts were sonicated with an ultra-
sonic cell disrupter (Microson, Farmingdale, NY) and
clarified by centrifugation at 10,000 g. Proteins were
subjected to SDS-PAGE and transferred to nitrocellulose
filters (Schleicher and Schuell). Filters were blocked with
TBS-T (50 mM Tris–HCl, pH 7.5, 150 mM NaCl and 0.5%
Tween 20) containing 5% (w/v) BSA, incubated overnight
at 4 jC with the primary antibodies, washed with TBS-T
and incubated for 1 h with HRP-conjugated goat anti-mouse
or goat anti-rabbit IgG (Zymed laboratories, San Francisco,
CA). Signals were generated with an ECL kit (Pierce).
Densitometric analyses of the signals were performed using
the Gel-Pro software.
The following primary antibodies were used: anti-PHAS-
I polyclonal antibody [43], diluted 1:3000; anti-phosphory-
lated ERK polyclonal antibody (Promega, Madison, WI),
diluted 1:5000 and 1:2000, respectively; anti-phosphoserine
polyclonal antibody (Chemicon, Temecula, CA), diluted
1:1500; anti total Akt (1:1000, Cell Signaling, Beverly,
MA); anti-phosphorylated Akt monoclonal antibody (Prom-
ega), diluted 1:2500; anti-eIF4E monoclonal antibody
(Transduction Laboratories), diluted 1:3000; monoclonal
anti-cyclin D1 antibody (1:1000, Santa Cruz Biotechnology,
Santa Cruz, CA); and monoclonal anti a-tubulin (1:1000,
Oncogene, Darmstadt, Germany).
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2.6. Statistics
Unless otherwise indicated, data were analyzed using
one-way or two-way ANOVA. Comparisons of individual
groups were performed using Tuckey honest test. The
significance level was set to P < 0.05 for all experiments.
3. Results
3.1. LELI promotes de novo protein synthesis in serum-
starved myogenic cells
The effect of LELI on de novo protein synthesis was
tested in i28 myoblasts that had been rendered quiescent by
serum deprivation for 36 h. Cells were labeled for 2 h with
[35S]methionine immediately after irradiation or 2, 4 or 6 h
thereafter. Control, nonirradiated cells underwent the same
experimental procedure. The overall level of protein syn-
thesis was significantly higher in the LELI groups com-
pared to controls (two-way ANOVA F(1,8) = 18.41;
P < 0.0026; Fig. 1A). Specifically, LELI induced threefold
the incorporation of [35S]methionine over the control dur-
ing the first 2 h after irradiation. In both LELI and control
cells, methionine incorporation was significantly reduced
during the second 2-h period, remaining relatively low in
controls but induced again in the LELI cells. A fourfold
difference in [35S]methionine incorporation was observed
between control and LELI-treated cells at 8 h post-irradi-
ation.
To study the effect of LELI on protein translation
process, cells were labeled with [35S]methionine for a short
interval of 20 min immediately after LELI (Fig. 1B). During
that time period, a significant increase in [35S]methionine
incorporation was observed in the LELI vs. control cells (t-
test: two-sample assuming unequal variances, P= 0.012),
suggesting the induction of protein translation of pre-exist-
ing mRNA upon LELI.
To confirm this hypothesis, we tested the expression of
cyclin D1, which is subjected to translational control
[35,44–47]. Higher cyclin D1 levels (approximately four-
fold) were detected in the LELI-treated cells than in their
respective controls as early as 6 min post-irradiation. The
levels of cyclin D1 were sustained at 15 min post-irradi-
ation, however, were lower than those in the proliferating
myoblasts (Fig. 1C).
3.2. LELI induces eIF4E phosphorylation in myoblasts
eIF4E has been shown to play a key role in protein
translation. To study the effect of LELI on the expression
and phosphorylation of eIF4E, serum-deprived i28 cells
were allocated to one of three experimental groups: (i)
nonirradiated control cells (control); (ii) LELI-treated cells
(LASER); (iii) 10% FCS-supplemented cells, serving as a
positive control for stimulation of proliferation. These cells
were serum-refed for the time needed to irradiate one petri
dish, and thereafter were maintained in DMEM alone (10%
FCS). Cells were harvested at 15 and 90 min post-irradiation
and analyzed for the expression or phosphorylation of eIF4E
(Fig. 2). eIF4E phosphorylation was induced after 15 min in
LELI- and FCS-treated cells. In the LELI cells, high levels
of phosphorylated eIF4E were maintained until 90 min after
irradiation (Fig. 2A), and were compatible to those in the
proliferating cells. Total levels of eIF4E were not signifi-
cantly affected by either LELI or serum re-feeding (Fig.
Fig. 1. Time-course analysis of the effect of LELI on total protein synthesis.
i28 cells were serum-deprived for 36 h, after which they were either laser-
irradiated for 3 s (solid columns) or served as controls (open columns).
After LELI, cells were incubated for the indicated periods and metabolically
labeled. [35S]methionine was added for the last 2 h of the incubation (A), or
for 20 min immediately after irradiation (B). Incorporation of labeled
methionine into proteins was determined in 10-Al aliquots of TCA-
precipitated whole-cell extract. These data are the meanF S.E. of three
independent experiments. Asterisks indicate a significant difference
( P< 0.05) from respective controls. (C) Cyclin D1 protein expression
was visualized at various times after irradiation using Western blot analysis
(upper panel). Densitometric analysis of cyclin D1 expression levels
relative to a-tubulin (lower panel). Proliferating cells were those maintained
in 20% FCS-containing medium.
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2B), suggesting that this protein is not regulated at the
translational level.
3.3. LELI regulates eIF4E via the MAPK/ERK pathway
eIF4E is rapidly phosphorylated on Ser209 in response
to mitogens and growth stimuli via the MAPK/ERK
pathway [48–50]. The MAPK/ERK-mediated effect of
LELI on eIF4E phosphorylation was tested in the presence
or absence of the noncompetitive MEK inhibitor,
PD098059 [51]. Serum-deprived i28 cells were supple-
mented with DMEM containing 50 AM PD098059, 30
min prior to irradiation. Positive-control plates were sup-
plemented with 10% FCS containing 50 AM PD098059.
Both LELI and FCS substantially induced phosphorylation
of eIF4E in the absence of PD098059 (Fig. 3, lane 1 vs.
lanes 2 and 4, Fig. 2A). This phosphorylation was
significantly reduced after incubation with PD098059
(Fig. 3, lanes 3 and 5). Activation of the MAPK pathway
is essential for cyclin D1 expression and provides a link
between mitogenic signaling and cell-cycle progression
[52]. Indeed, elevated levels of cyclin D1 were observed
in the LELI and serum-refed compared to control cells
(Fig. 3, lanes 1, 2 and 4; Fig. 1C). These levels were
Fig. 3. PD098059 inhibits LELI-induced eIF4E activation. i28 cells were
serum-deprived for 36 h with DMEM, followed by preincubation with 50
AM PD098059 (PD) for 30 min (+). Cells that were not preincubated with
the inhibitor are marked with ( ). Cells were then irradiated (LASER) or
supplemented with DMEM–10% FCS (10% FCS), and harvested 15 min
after irradiation or refeeding. Upper panel: Equal amounts (60 Ag) of
protein were either immunoprecipitated with anti-eIF4E antibody or reacted
with anti-cyclin D1 antibody. The immunoprecipitates were analyzed on
immunoblots using an anti-phosphoserine antibody. Equal protein loading
per lane was confirmed by immunoblot analysis with a-tubulin antibody.
Lower panel: Bands identifying the relative expression of phosphorylated
eIF4E and cyclin D were quantified by densitometric analysis and
normalized to that of a-tubulin. Data represent two independent experi-
ments.
Fig. 2. LELI induces phosphorylation of eIF4E but does not affect its
expression levels. i28 cells were serum-deprived for 36 h, after which they
were either irradiated for 3 s (LASER) or refed with DMEM containing
10% FCS (10% FCS) for the time needed to laser irradiate one petri dish.
Upon termination of irradiation the FCS-containing medium was replaced
with DMEM. Cells were harvested at the times indicated above the lanes
and equal amounts of protein (50 Ag) were electrophoresed and blotted.
Blots were probed with antibodies against phospho-eIF4E (A) and total
eIF4E (B). Equal loading of proteins was verified by reprobing the blots
with an antibody against a-tubulin. Bands identifying the relative
expression of phosphorylated eIF4E were quantified by densitometric
analysis and normalized to that of a-tubulin (A, lower panel). Results
represent one of four independent experiments.
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markedly reduced in the presence of PD098059 (Fig. 3,
lanes 3 and 5). Taken together, our results indicate that
LELI-induced eIF4E phosphorylation is mediated via the
MAPK/ERK pathway.
3.4. LELI affects PHAS-I phosphorylation
PHAS-I is an eIF4E-binding protein that mediates cap-
dependent translation [27]. In the presence of mitogens,
PHAS-I is phosphorylated and dissociates from eIF4E
[53,54]. Three isoforms of PHAS-I were detected in myo-
blasts (Fig. 4A): the non- and partially phosphorylated
isoforms that bind eIF4E (a and h), and the fully phos-
phorylated, slowest migrating isoform (g), which does not
bind eIF4E [37,38]. In serum-deprived cells, the dominant
h isoform of PHAS-I represented 80% of the total protein
(Fig. 4A, lane 1 and Fig. 4B). LELI and serum-refeeding
induced rapid phosphorylation of PHAS-I as early as 2 min
after treatment (Fig. 4A, lane 1 vs. lanes 2 and 3, and Fig.
4B). High levels of PHAS-I phosphorylation were main-
tained until 15 min after irradiation or serum-refeeding (Fig.
4A, lane 1 vs. lanes 4,5 and 6,7 and Fig. 4B). At 120 min
post-irradiation, the ratio between h and g isoforms was
equalized in the LELI-treated cells (Fig. 4A, lane 8). In the
FCS-refed cells, the high ratio between the g and h iso-
forms remained unchanged during consequent periods of
time, up to 120 min after refeeding (Fig. 4A, lane 9 and Fig.
4B).
3.5. LELI affects PHAS-I phosphorylation in a PI3K-
dependent manner
PI3K mediates growth factor and hormone-dependent
phosphorylation of PHAS-I [33,55,56]. Its involvement in
LELI-induced PHAS-I phosphorylation was examined,
using the specific PI3K inhibitor Wortmannin. Serum-
deprived myoblasts were LELI-treated, harvested 30 min
post-irradiation and immunoblotted to analyze PHAS-I
phosphorylation.
Laser irradiation resulted in significant PHAS-I phos-
phorylation, evidenced by high levels of the fully phos-
phorylated g isoform (Fig. 5, lane 1 vs. lane 2). Some effect
of Wortmannin on PHAS-I phosphorylation could be seen at
the concentrations of 10 9 to 10 7 M (Fig. 5, lanes 3 to 5).
At higher concentration of 10 6 M Wortmannin [57] there
was a threefold reduction in the level of the g isoform
obtained, reversing the g/h ratio approximately to control
levels (Fig. 5, lane 1 vs. lane 6). These data suggest that
LELI regulates PHAS-I phosphorylation in a PI3K-depend-
ent pathway.
We next examined the effect of LELI on Akt phosphor-
ylation, a downstream target of PI3K [58]. Serum-deprived
i28 cells were irradiated or serum-refed and lysed 6, 15 and
30 min later. Whole-cell extracts were analyzed by SDS-
PAGE and reacted with an antibody to the phosphorylated
form of Akt. Both LELI and FCS induced Akt phosphor-
ylation relative to controls (Fig. 6A). A densitometric
analysis revealed that the LELI effect was lower compared
to that of FCS, however, less transient (Fig. 6A, lower
panel). Neither LELI nor FCS treatments affected total Akt
expression levels (Fig. 6B).
Wortmannin supplemented at the concentrations of 10 8
and 10 7 M did not affect the level of phosphorylated Akt
(Fig. 6C). Akt phosphorylation was suppressed at a higher
Fig. 4. LELI-induced PHAS-I phosphorylation. (A) i28 cells were treated as
in Fig. 2, lysed 30 min after irradiation, and 60-Ag protein was analyzed by
immunoblotting with anti-PHAS-I antibody. (B) Signals of the individual
PHAS-I forms were analyzed by densitometry and expressed as percentages
of the total intensity of the three PHAS-I forms. These data are
representative of three separate experiments.
Fig. 5. LELI-induced PHAS-I phosphorylation is Wortmannin-sensitive.
i28 cells were serum-deprived for 36 h, after which they were preincubated
for 30 min with various concentrations of Wortmannin, after which they
were or were not irradiated. Equal amounts of proteins were analyzed by
17% SDS-PAGE, transferred to a nitrocellulose membrane, and immuno-
blotted with an antibody against PHAS-I. A representative autoradiograph
of two experiments is shown (upper panel). Signals of the individual
PHAS-I forms were quantitated by densitometry and expressed as
percentages of the total intensity of the three PHAS-I forms (lower panel).
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level of 10 6 M, arguing for activation of the PI3K pathway
following LELI.
4. Discussion
In light of previous studies demonstrating enhanced
satellite cell proliferation and cell-cycle progression follow-
ing LELI, the working hypothesis of this study was that
these processes are mediated by increased de novo protein
synthesis. Indeed, a rapid and significant induction of de
novo protein synthesis in skeletal muscle satellite cells was
evident within the first 20 min after LELI. This finding is in
agreement with an earlier study showing a higher protein
synthesis with a similar time course, in He–Ne laser-
irradiated rat hepatocytes [41]. The augmentation in newly
synthesized proteins implies that shortly after irradiation,
translation of pre-existing mRNAs has occurred. Most of
these pre-existing mRNAs possess complex 5V secondary
structures and code for growth-related genes, such as
ornithine decarboxylase (ODC; [59,60]) and cyclin D1
[45,47,61]. The translation of such mRNAs is selectively
enhanced upon mitogenic stimulation [35]. Indeed, induc-
tion of cyclin D1 expression was detected in LELI cells as
early as 6 min after irradiation, suggesting that the increased
synthesis following LELI involves the translation of pro-
teins that are required for entrance and progression through
the G1 phase of the cell cycle.
Induction of protein synthesis during the first 2 h after
irradiation was followed by a decline and a second induction
6 to 8 h after irradiation in LELI cells. These fluctuations in
protein synthesis resemble those seen under mitogenic
stimulation, and may result from the effect of LELI on the
synthesis of proteins participating in later stages of G1
phase of the cells cycle [62].
To elucidate the contribution of LELI to the regulatory
pathways of protein synthesis, we studied its effect on the
levels and activity of eIF4E, which plays a key role in
translation initiation. LELI induced eIF4E phosphorylation
without affecting its expression levels. The MEK inhibitor
PD098059 abolished eIF4E phosphorylation, suggesting
that LELI-induced eIF4E phosphorylation is Ras/Raf/
ERK-dependent. This finding confirms our previous obser-
vations that LELI specifically activates the MAPK/ERK
pathway and consequently induces satellite cell proliferation
[17,19].
Fig. 7. A proposed model for LELI signaling in skeletal muscle satellite
cells.
Fig. 6. LELI-induced Akt phosphorylation is Wortmannin-sensitive. i28
cells were treated as described in Fig. 2. Cells were then lysed at the
indicated periods of time after irradiation. Equal amounts of proteins were
analyzed by 12.5% SDS-PAGE, transferred to a nitrocellulose membrane,
and immunoblotted with an antibody against phosphorylated (Ser473) Akt
or a-tubulin (A). A representative autoradiograph of two experiments is
shown (A, upper panel). Signals of Akt were quantitated by densitometry,
normalized to the level of a-tubulin and are presented relative to the amount
of phosphorylated Akt detected zero time (control) (A, lower panel). A
parallel experiment to (A) shows that total Akt expression was not affected
by LELI nor by serum treatment (B). (C) i28 cells were treated for 30 min
with various concentrations of Wortmannin and then either irradiated (+) or
kept aside ( ).
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Although eIF4E phosphorylation is Ras/Raf/ERK-
dependent, MAPK/ERK does not directly activate eIF4E.
Previous studies have shown that p38 MAPK or MAPK/
ERK phosphorylate (in vivo and in vitro) mitogen-acti-
vated protein kinase signal-integrating kinases 1 and 2
(Mnk1 and Mnk2), which in turn phosphorylate eIF4E
[50,63–67]. In response to stress agents (NaCl or aniso-
mycin), Mnk1 is phosphorylated by p38 MAPK but not by
MAPK/ERK. Nonetheless, in the presence of growth
stimuli, ERK was more potent at phosphorylating Mnk1
than p38 was [50]. Moreover, in contrast to Mnk1, Mnk2
retains significant activity in the presence of both ERK and
p38 inhibitors (PD098059 and SB203580, respectively;
[67]). Given that eIF4E phosphorylation was abolished in
the presence of PD098059, and that LELI does not affect
p38 MAPK phosphorylation [19], we suggest that LELI
induces eIF4E phosphorylation via Mnk1 phosphorylation
(Fig. 7).
eIF4E activity is also regulated by PI3K-dependent
PHAS-I phosphorylation [39]. The fully phosphorylated
isoform of PHAS-I dissociates from eIF4E, allowing
initiation of translation [37,38]. In this study, we demon-
strate that LELI induced the phosphorylation of PHAS-I,
which was abolished by the addition of the PI3K inhibitor
Wortmannin, suggesting this phosphorylation to be PI3K-
dependent. Moreover, LELI induced the phosphorylation
of Akt, a downstream target of PI3K in a Wortmannin-
dependent manner (Fig. 7). It has been reported that Akt
affects downstream survival and death factors as well as
regulatory proteins involved in the control of translation
[68]. Akt directly phosphorylates mTOR, which in turn
induces PHAS-I phosphorylation [27,58,69,70]. Taken
together, we suggest that PI3K-dependent phosphorylation
of Akt mediates the effect of LELI on PHAS-I phosphor-
ylation and eIF4E availability to the translation machi-
nery.
In this study we demonstrated a prolonged effect of
LELI on PHAS-I as well as on Akt phosphorylation
compared to the FCS refed cells. This phenomenon might
explain the prolonged effect observed for eIF4E phos-
phorylation, which occurs downstream to both Akt and
PHAS-I. Such a prolonged effect of LELI on infracted
heart was reported in vivo in previous studies [71].
Notably, FCS contains a mixture of various growth
factors, which may account for the higher induction of
phosphorylation.
We report here that LELI induces de novo protein
synthesis by modulating the activity of key enzymes that
regulate capped mRNAs translation. Consistent with the
data presented in this and previous studies [17,19], we
propose a model that summarizes our findings (Fig. 7).
Identifying the consequences of LELI on translation
initiation, which is a prerequisite for muscle proliferation
and hypertrophy, is important for establishing the thera-
peutic potential of LELI in cases of muscle injury or
atrophy.
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